Vancouver, British Columbia – July 25, 2017 – GLOBAL HEMP GROUP INC. (“Global Hemp”, “GHG”, or the “Company”) (CSE:GHG / FF:GHG / OTC:GBHPF) an industrial hemp and cannabis corporation is pleased to announce that Health Canada has renewed its Industrial Hemp License for the current year, which for 2017 will include the ability to cultivate hemp.
Since renewing its license, the Company has launched the first phase of a multi-phase industrial hemp project on the Acadian peninsula of New Brunswick, which is envisioned to culminate in the development of GHG’s first Hemp Agro-Industrial Zone, or HAIZ.
This first phase of the project is a hemp cultivation and research trial. Dr. Paul Perrault, a Development Economist and Director of GHG visited the region in mid-May where he met with officials from the Department of Agriculture, Aquaculture and Fisheries (DAAF), Opportunities New Brunswick, and several farmers in the area . With the support of Mr. Jesse Chiasson, Development Officer at the DAAF, a number of farmers were enlisted in the project on a protocol to test three varieties of industrial hemp. A field agronomist was recruited to oversee the trials, with results expected later this year. GHG is in ongoing discussions with a local research partner to collaborate on these trials.
GHG’s HAIZ concept engages farmers, processors providing a variety of proprietary disruptive technologies, and manufacturers to collaboratively produce and process 100% of the hemp plant into a number of wholesale materials that can be manufactured into tens of thousands of healthy and sustainable products. The HAIZ will be surrounded by hemp production thereby minimizing the cost of expensive transportation to distant processing facilities. The HAIZ will produce social and environmental benefits to the community, and value for investors in the Company. These zones will create jobs for farmers, foster rural development, provide the opportunity to develop more sustainable products of superior quality and help support GHG’s commitment to creating a carbon free economy.
“We are very pleased to have begun hemp trials in New Brunswick with the support of DAAF and we expect to secure a local research partner for the project very soon. We see great potential for this Maritime Province to take advantage of this socially, environmentally and economically beneficial crop,” said CEO, Charles Larsen.
The Company is also pleased to announce the launch of its new corporate website; GlobalHempGroup.com. Information and pictures on the New Brunswick hemp trials can be found on the website in the Projects section.
Mr. Larsen said, “We are happy to have launched our new corporate website that reflects the new direction of Global Hemp Group. Hill & Drakoln built a beautiful site for GHG.”
GHG management continues to evaluate additional hemp and cannabis projects in both Canada and the United States.
About Global Hemp Group Inc.
Global Hemp Group (“GHG”) is a publicly traded company founded in 2012, headquartered in British Columbia, Canada with base operations in Montreal and Southern California. The Company is focused on the production and processing of hemp and cannabis, and collaboration with companies that will enable GHG to develop and implement the Hemp Agro-Industrial Zone concept. Through partnerships, joint ventures and acquisitions, the Company will capture cash flow, revenues and value, and establish a greater collective valuation.
Forward Looking Statements Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.